OMEGA HEALTHCARE INVESTORS INC
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
OHI$48.83+1.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| | | | | | | |
|---|---|---|---|---|---|---|
| · · September 30, · · December 31, | ||||||
| · · 2026 · · 2025 | ||||||
| · · (Unaudited) · · · | ||||||
| ASSETS · · · · · | ||||||
| Real estate assets · · · · | ||||||
| Buildings and improvements | | $7,866,193 | $7,901,652 | |||
| Land | | | 1,196,222 | | | 1,179,463 |
| Furniture and equipment | | | 542,504 | | | 539,775 |
| Construction in progress | | | 21,071 | | | 12,492 |
| Total real estate assets | | | 9,625,990 | | | 9,633,382 |
| Less accumulated depreciation | | (3,061,110) | (2,930,611) | |||
| Real estate assets – net | | 6,564,880 | 6,702,771 | |||
| Real estate loans receivable – net | | 1,345,599 | 1,380,949 | |||
| Investments in unconsolidated entities | | 494,764 | 414,127 | |||
| Assets held for sale | | 1,297 | 4,000 | |||
| Total real estate investments | | | 8,406,540 | | | 8,501,847 |
| Non-real estate loans receivable – net | | 254,537 | 330,322 | |||
| Total investments | | 8,661,077 | 8,832,169 | |||
| | | | | | | |
| Cash and cash equivalents | | 195,897 | 27,024 | |||
| Restricted cash | | 27,708 | 27,539 | |||
| Contractual and other receivables – net | | 275,191 | 280,774 | |||
| Goodwill | | 648,550 | 644,626 | |||
| Other assets | | 312,850 | 236,927 | |||
| Total assets | | $10,121,273 | $10,049,059 | |||
| | | | | | | |
| LIABILITIES AND EQUITY | | | | |||
| Revolving credit facility | | $— | $242,000 | |||
| Senior notes and other unsecured borrowings – net | | 4,020,927 | 4,014,011 | |||
| Accrued expenses and other liabilities | | 337,279 | 352,549 | |||
| Total liabilities | | 4,358,206 | 4,608,560 | |||
| | | | | | | |
| Preferred stock $1.00 par value authorized – 20,000 shares, issued and outstanding – none | | | — | | | — |
| Common stock $0.10 par value authorized – 700,000 shares, issued and outstanding – 303,854 shares as of September 30, 2026 and 295,539 shares as of December 31, 2025 | | 30,385 | | 29,553 | ||
| Additional paid-in capital | | 9,047,164 | | 8,693,033 | ||
| Cumulative net earnings | | 5,274,056 | | 4,677,092 | ||
| Cumulative dividends paid | | (8,903,042) | | (8,297,416) | ||
| Accumulated other comprehensive income | | 57,527 | | 79,037 | ||
| Total stockholders’ equity | | 5,506,090 | | 5,181,299 | ||
| Noncontrolling interest | | 256,977 | | 259,200 | ||
| Total equity | | 5,763,067 | | 5,440,499 | ||
| Total liabilities and equity | | $10,121,273 | $10,049,059 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.